Reaction
Incorrect Dose Administered By Product reporting signals
As of the last recalculation, Incorrect Dose Administered By Product appears in 1,500 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE (PRR 60.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 44 | 60.2 | 60.4 |
| Ciclesonide | 27 | 28.0 | 28.0 |
| Erenumab-Aooe | 89 | 23.8 | 23.8 |
| Estradiol | 98 | 16.8 | 16.8 |
| Evolocumab | 166 | 15.8 | 15.9 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 17 | 15.3 | 15.3 |
| Estradiol Gel 0.1% | 45 | 14.2 | 14.2 |
| Estradiol Transdermal | 45 | 14.2 | 14.2 |
| Oral Semaglutide | 68 | 13.4 | 13.4 |
| Prednisolone Acetate | 9 | 12.1 | 12.1 |
| Timolol Maleate | 8 | 11.3 | 11.3 |
| Fremanezumab-Vfrm | 7 | 8.5 | 8.5 |
| Benralizumab | 12 | 8.4 | 8.4 |
| Brimonidine Tartrate | 10 | 7.8 | 7.8 |
| Canakinumab | 6 | 7.7 | 7.7 |
| Rivastigmine | 10 | 7.4 | 7.4 |
| Guselkumab | 16 | 6.3 | 6.3 |
| Lifitegrast | 7 | 6.0 | 6.0 |
| Methylphenidate | 12 | 5.8 | 5.8 |
| Bimatoprost | 10 | 4.8 | 4.8 |
| Travoprost | 3 | 4.8 | 4.8 |
| Abaloparatide | 10 | 4.7 | 4.7 |
| Esketamine Hydrochloride | 4 | 3.1 | 3.1 |